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1. INTRODUCTION 
 
              In siddha system of medicine is profunded by Agathiyar and his clan of 18 
siddhars. The siddha system is amalgam and inseparable from tamil.  
 
              The department of gunapadam is doing continues research, This drug 
evaluation is done by animal study, ICP OES, SEM analysis for heavy metals and 
particle size respectively, and to determine Acute, Sub Acute And Sub Chronic Study. 
 
            The selected drug Vellai Parpam was tried in animal models.  The various 
dose of the drug acute [5mg/kg up to 2000mg/kg (5, 50, 300, 2000mg/kg)], sub acute 
(200 mg/kg and 400 mg/kg for 28 days) and sub chronic toxicity study were tried.  
The animals were validated to routine parameters of haematology, urology, lipid 
profile, diuretic, anti urolithiasis and anti inflammatory studies were studied. 
 
           The selected drug Vellai Parpam is a sasthric preparation authored by 
Agathiyar Vaithiya Kaaviyam 1500.published by V. R.Madhavan.  The standard 
operative procedure were standardized and  chemical analysis were carried out. The 
dose calculation was converted human dose to animal dose. 
 
             Low dose =    Human dose 400 mg × 0.018(200 gms of rat) 
                              =    7.2 mg  
            Mid dose   =    low dose × 5 
                              =   7.2 ×5 = 36 mg 
            High dose  =   low dose × 10 
                               =  7.2 × 10 = 72 mg. 
 
          The doses were calibrated use in standard scientific procedure subjected by 
pharmacologist and toxicologist in our institute.  All the protocols and the 
experiments conducted in strict compliance according to ethical principles and 
guidelines provided by committee for the purpose of control and Supervision of 
Experiments on Animals (KKCP/2015/4529) .Animal experimentation protocols are 
approved by Institutional Animal Ethical Committee. 
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        As per the chemical analysis observation of the drug composition has diuretic, 
anti urolithiasis and anti inflammatory activities and animal study reviews the drug 
through histopathology study of the drug has no adverse reaction and no 
psychological abnormalities. The blood parameters showed has no erythrolysis, 
cumulative toxicities. So the drug may be tried for clinical study in future. 
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2. AIM AND OBJECTIVES  
 
Aim: 
 To Evaluate The Safety And Pharmacological Profile Of The Test Drug 
In The Animal Models. 
 
Objective: 
 
 Review of various information (Siddha and modern) relevant to the study. 
 Preparation of the drug as per classical Siddha literature. 
 Standardization of  the  prepared drug  
 
 Physicochemical analysis 
 Chemical analysis to evaluate acidic and basic radicals. 
 ICP-OES  Inductively Coupled Plasma Optical Emission Spectrum 
 SEM  Scanning Emission Microscopy 
 
   Toxicity studies: 
 Acute oral toxicity study by OECD  423 Guideline. 
 Repeated dose  28 days oral toxicity study by OECD  407 Guideline.  
 Repeated dose  90 days oral toxicity study by OECD  408 Guideline. 
 
    Pharmalogical activities in wister albino rats 
 
 Anti-Urolithiatic activity by ethylene glycol induced urolithiasis method     
 Diuretic activity by lipschitz method                    
 Anti-inflammatory activity by carrageenan induced paw edema method 
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AND 
METHODS 
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3. MATERIALS AND METHODS 
      Standard Operative Procedure 
 
Drug selection:  
 Vellai parpam  were taken as a trial drug from the Siddha literature 
hiya kaaviyam- , Author:R,Madhavan  
Ingredients: 
       Purified Karpoora silasathu (Selenite)       -   1 palam (35 gm) 
       Purified Porikaram (Borax)                        -   1 palam (35 gm) 
 Decoctions: 
       Paruthi ver (Gossypium herbaecum)           -    1 palam (35 gm) 
       Athiver thol (Ficus racemosa)                     -    1 palam (35 gm) 
 
         Egg white                                                   -     Q.s  
 
Collection of the Plant materials 
 All plant materials were freshly collected from in and around Gingee, 
Villupuram Dt, Tamilnadu. 
Some drugs were procured from raw drug shop in Parrys, Chennai. 
Identification and Authentication of the drug  
All the plant materials were identified and authenticated by the Botanist, 
Department of  Gunapadam ,  National Institute of Siddha. 
The identity and authenticity of the mineral drugs were confirmed by 
Dr.E.Sasikala,       Pharmacognosist, Siddha Central Research Institute, Chennai. 
 
Purification of the drugs 
 All the drugs mentioned here were purified as per the Siddha literature.
 Roots of Ficus racemosa and Gossypium herbaecum was washed in the 
running tap water to remove the soil and impurities. 
 The karpoora silasathu was purified by boiling it in tender coconut water until 
the water evaporates. The drug is removed, washed and  then dried. 
 Vengaram  was fried using  heat until the removal of its entire water content. 
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Ingredients before and after purification 
VENGARAM 
            
 
                                       
                 
 
 
 
 
 
KARPOORA SILASATHU 
 
 
 
 
 
 
 
                                                         
 
ATTHI VER 
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PARUTHI VER 
                                                         
 
 
 
 
 
 
 
 
                                                     
EGG WHITE 
 
 
 
 
 
 
 
 
 
 
 
VELLAI PARPAM 
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Preparation of the Drug 
Procedure 
 The decoction will be prepared from Athiver thol and Paruthiver  
 The karpoorasilasathu and porikaram Will be powdered and ground  with the 
above decoction and made in to villai, which is subjected to putam process 
with 5 cow dunk cakes 
 The same process will be repeated with egg white finally the parpam will be 
collected and stored in air tight container. 
 
Labelling:  
   
Name of the preparation   : Vellai Parpam 
Date of preparation 
                  
: 8/6/2014  and  15/2/2015 
Therapeutic dose    : 200 mg twice a day 
Adjuvant/Vehicle : Honey 
             Indication : 
 
Kalladaippu,               
Mahotharam,Neer chiruppu. 
Date of expiry : 100 years 
   
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF 
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4. LITRATURE REVIEW 
 
4.1. GUNAPADAM REVIEW 
1. «ò¾¢ Ficus glomerulata roxb 
§ÅÚ ¦ÀÂ÷ :  
 
 
ÀÂýÀÎõ ¯ÚôÒ :  
§Å÷. 
 
Í¨Å :  ÐÅ÷ôÒ  
 
¾ý¨Á :  ¾ðÀõ 
 
À¢Ã¢× :  ­É¢ôÒ 
 
¦ºö¨¸ :  ÐÅ÷ôÀ¢ 
   ÌÕ¾¢ ¦ÀÕì¸¢ 
 
Ì½õ : 
  
        Å£Ú ¸ÎôÀ¢Ãò¾õ ¦Åñº£¾ Ãò¾¦Á¡Î        
        ¿¡ÚÅ¢Ã ½í¸¦ªÄ¡õ ¿¡¼¡Å¡õ-ÜÚí¸¡ø 
        «ò¾¢¾Õ §Á¸õ§À¡õ ¬Â¢¨Æ§Â! ±ï»¡ýÚõ 
        «ò¾¢ôÀ¡ü Àð¨¼ì ¸È¢ . 
              -  «¸ò¾¢Â÷ Ì½Å¡¸¼õ. 
 
      ¸£úÅ¡öì ¸ÎôÒ, ÌÕ¾¢ô§À¡ìÌ, º£¾ì¸Æ¢îºø, ¿¡üÈÓûª Òñ¸û,  
¦Åû¨ª ¬¸¢Â¨Å¸¨ªô §À¡ìÌõ. 
 
 
 
 
 
9 
 
 
ÀÂý  
 «ò¾¢ À¡ø - À¢ò¾§¸¡Àõ, ¿£Ã¢Æ¢×, ­Ãò¾ ãò¾¢Ãì¸¢Ã¢îºÃõ §À¡ìÌõ. 
 ÁÃ§ÅÃ¢Ä¢ÕóÐ ­ÈíÌõ ¸ûª¢ø, º£É¢§ÂÛõ, §ÀÂý 
Å¡¨Æì¸É¢§ÂÛí ÜðÊ ¿¡§¼¡Úõ Å¢ÊÂü¸¡¨ÄÂ¢ø ¯ð¦¸¡ûª, 
¯ðÝÎ, À¢ò¾ ÁÂì¸õ, ¿£÷§Åð¨¸ Ó¾Ä¢Â¨Å¸û ¾½¢ìÌõ. 
 
§ºÕõ À¢È ÁÕóÐ¸û : 
¯û ÁÕóÐ¸û  
Á¢ªÌ ¨¾Äõ : 
¾£Õõ §¿¡ö :   °¾ø §¿¡ö, «º£Ã½õ. 
 
4.2. ÀÕò¾¢  
§ÅÚ ¦ÀÂ÷ :  
          ¬îº¡¾ ¿À¨Ä, ÀÃ¢, ¯ò¾¢Ã¢, ¸¡üÀ¡ºõ, ÀýÉø. 
ÀÂýÀÎõ ¯ÚôÒ :  
                   §Å÷ôÀð¨¼. 
Í¨Å :  ÐÅ÷ôÒ, ­É¢ôÒ. 
¾ý¨Á :  ¦ÅôÀõ 
À¢Ã¢× :  ¸¡÷ôÒ 
 
¦ºö¨¸ : 
       º¢Ú¿£÷ ¦ÀÕì¸¢ 
       ÕÐ×ñ¼¡ì¸¢ 
       ¯ûªÆÄ¡üÈ¢ 
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ÀÂý : 
 º£ú¦Åû¨ª, ÌÕ¾¢ ¦Åû¨ª, ÌÕ¾¢ÂÆø §¿¡ö, Òñ, Å£ì¸õ 
­¨Å¸Ùõ ¿£íÌõ.  
 Àïº¢Ä¢ÕóÐ, " ¸ý ¸¡ð¼ý " ¯õ, «¾¢Ä¢ÕóÐ ¦¸¡§Ä¡Ëý 
¯õ ¦ºöÂÄ¡õ. ­õÁÕó¨¾ ¦ÅðÎì¸¡Âí¸ª¢ý Á£Ð ¾¼Å, 
«ó¾ ­¼õ º£ì¸¢Ãõ ÅÈñÎ§À¡õ. «ùÅ¢¼ò¾¢ø ´ÕÅ¨¸î 
¦º¾¢û §À¡ýÈ ´ýÚ ãÊì¦¸¡ñÎ, ÒÈì¸¡üÚ, ÑñÒØ 
Ó¾Ä¢ÂÉ ¯ðÒ¸¡¾ÀÊ ¸¡ìÌõ.  
 
§ºÕõ À¢È ÁÕóÐ¸û : 
¯û ÁÕóÐ¸û : 
âÃ½¡¾¢ ­ª¸õ : 
     ¾£Õõ §¿¡ö¸û    :  «Æø §¿¡ö, ãÄÅ¡ö×. 
Á¸¡Å¢øÅ¡¾¢ ­ª¸õ :  
     ¾£Õõ §¿¡ö¸û    :  Å£ì¸õ, ¯ôÀ¢º §¿¡ö, 40 Å¨¸ «Æø §¿¡ö¸û. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
¸üâÃ º¢Ä¡ºòÐ 
 
¯ÀÃºõ -120 ø ´ýÚ. º¢Ä¡ºòÐ ±ýÀÐ º£¨Ä+ºòÐ ±É À¢Ã¢óÐ 
Á¨ÄÂ¢Û¨¼Â ºò¨¾ì ÌÈ¢ìÌõ. 
¸¢¨¼ìÌõ ­¼õ & §¾¡üÈõ: 
 
               ÓÐ§ÅÉ¢ü ÀÕÅó¾ýÉ¢ø ¦Á¡öì¸¾¢÷ ¦ÅôÀõ ¾¡ì¸õ 
               ¦Å¾¢÷ ¦ºÈ¢Â¢ ÁÂÁ¡¾Å¢Âý Å¨Ãì ¸½¢¸ §Ä¡¸õ 
               ÁÐ¦ÅÉ «Õ¸¢ ¿¡Ùõ Á¡ÛÚ À¢º¢¨É §À¡ýÈ 
               À¾¢¸¢Ä¡ ¦Åª¢Â¢ü §È¡ýÚõ ÀñÒ¨¼ Ãºõ º¢Ä¡ºòÐ  
 
                                          §À¡¸÷ 7000 -3õ ¸¡ñ¼õ. 
 
 ÓÐ§ÅÉ¢ü ÀÕÅò¾¢ø ÝÃ¢Â ¦ÅôÀò¾¢É¡ø Á¨Ä¸ª¢Öûª ¦À¡ý, ¦ºõÒ,  
¦Åûª¢ §À¡ýÈ ¯§Ä¡¸í¸û ¯Õ¸¢, À¢º¢ý §À¡ø ¸º¢óÐ ÅÕÅÐ 
º¢Ä¡ºòÐ.  
 §¿À¡ªò¾¢ø ÐÅ÷ôâÁ¢Â¢Ä¢ÕóÐõ ±Îì¸ôÀÎ¸¢ÈÐ. 
 
Í¨Å, ¾ý¨Á, & À¢Ã¢× : 
            Í¨Å       -      ­É¢ôÒ 
            ¾ý¨Á      -      ¾ðÀõ 
            À¢Ã¢×        -      ­É¢ôÒ 
 
ºòÐÕ & Á¢òÐÕ ºÃìÌ : 
           ºòÐÕ         -    º£Éõ, ¸¡ó¾õ, ¦Åñ¸¡Ãõ, ­ÕõÒ 
           Á¢òÐÕ         -    ¿¡¸õ 
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Àïº â¾ò¾¢ø º¢Ä¡ºòÐ : 
          À¢Õò¾¢Å¢Â¢ý ÜÚ 
 
§¾÷× ¦ºöÔõ Ó¨È : 
          1. ¦¿ÕôÀ¢ý Á£Ð ¨Åò¾¡ø Ò¨¸Â¡Áø ­Õì¸ §ÅñÎõ. 
          2. ¸õÀ¢ ¸õÀ¢Â¡¸ À¢Ã¢Â §ÅñÎõ. 
          3. ¾ñ½£Ã¢ø §À¡ð¼¡ø ¾ñ½£ÕìÌû ¸Â¢Ú §À¡ø ¿£ª §ÅñÎõ. 
 
Ì½õ :  
      ¸üâÃò¾¢ý Á½Óõ, ¦Åñ¨Á ¿¢ÈÓõ ¦¸¡ñÎ ­ÕìÌõ. 
 
¦À¡Ð Ì½õ : 
          "¸øÄ¨¼ôÒ §Á¸í¸ÉàÄõ Å¢ò¾¢Ã¾¢           
           ¦º¡øÄ¨¼ìÌ ¿£ÃÕÚ¸ü §º¡½¢¾ì¸¡ý -¦ÁøÄ¢¨¼Â¡÷ì            
           ¸¢øÄ¸îºò ¾¢ø¨Ä¦ÂÛ Á¢ó¾¢Ã¢Â ¿ð¼ÓÁ¡í             
           ¸øÄ¸îºó ¾¢ø¨Ä¦ÂÛí ¸¡ø". 
 
 ¸øÄ¨¼ôÒ, º£§Á¸õ, «¾¢àÄõ, Å¢ò¾¢Ã¾¢, ãò¾¢Ãì¸¢Ã¢îºÃõ, §º¡½¢¾Å¡¾õ  
 §À¡Ìõ. 
§ºÕõ À¢È ÁÕóÐ¸û : 
¯û ÁÕóÐ¸û  
¸üâÃº¢Ä¡ºòÐ ÀüÀõ : 
¾£Õõ §¿¡ö       :   §Áø ±Ã¢×, À¢ò¾ ¦Åð¨¼, ¿£÷ì¸ÎôÒ. 
 
ÀÅÆ º¢Ä¡ºòÐ ÀüÅõ : 
¾£Õõ §¿¡ö       :  ¦Åð¨¼, ¦Åû¨ª, ¿£÷ÍÕìÌ. 
 
¸¡ÃÝ¼ºòÐ ÀüÀõ : 
¾£Õõ §¿¡ö     :    ¿£Ã¨¼ôÒ, ¸øÄ¨¼ôÒ, º¨¾Â¨¼ôÒ, ¿£÷ì¸ðÎ. 
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¦Åí¸¡Ãõ 
           ¦Åí¸¡Ãõ ¸¡Ãº¡Ãõ 25 ø ´ýÚ ¬Ìõ. 
 
§ÅÚ ¦ÀÂ÷ : 
           ¦À¡Ã¢¸¡Ãõ, Å¼í¸õ, ¯Õì¸¢Éõ, ¸¡Ãõ, ¯ÕìÌÁ¢ò¾¢Ãý, 
¼í¸½õ, àÁò¨¾Â¼ì¸¢. 
§À¡¸÷ ¿¢¸ñÎ - 1200 Â¢ø, 
           Íó¾¡½¢, Ì§¼¡Ã¢, ¬í¸¡Ã¢, Á½¢¸¡Ã¢. 
 
¸¢¨¼ìÌõ ­¼õ : 
         ¸Ä¢§À¡÷É¢Â¡Å¢Öûª ¸¢ª¢Â÷ ²Ã¢Â¢Öõ, ¦ÀÕ ±ýÈ ­¼ò¾¢Öõ, 
­ó¾¢Â¡Å¢ø ¾¢¦Àò, §¿À¡ªõ Ó¾Ä¢Â ­¼í¸ª¢Öõ ¯ûª ²Ã¢¸ª¢ø 
¿£÷ÅüÈ¢É¡ø ¯ôÒ ¯¨ÈóÐ ¸¢¨¼ì¸¢ÈÐ. 
 
Ì½í¸û : 
 ¦Åñ¨ÁÂ¡¸ º¢Ä §¸¡½í¸Ù¼ý Á¢ÛÁ¢ÛôÀ¡¸ ­ÕìÌõ. 
 ¿£Ã¢ø ¸¨ÃÔõ.  
 º¡Ã¡Âò¾¢ø ¸¨ÃÂ¡Ð. 
 ¸¡üÚôÀÎõÀÊ ¨Åò¾¡ø ¯ôÀ¢ý §Áø ¦Åñ½¢Èò àû ÀÊÔõ. 
 ¦À¡Ã¢ò¾¡ø «¾¢Ä¢ÕóÐ ¿£÷ ÍñÊô ¦À¡Ã¢óÐ «¾¢ø º¢È¢Â  
                ÐÅ¡Ãí¸û §¾¡ýÚõ. 
 
º¢ÈôÒ Ì½õ : 
 64 ºÃì¨¸Ôõ ¸ðÎõ. 
 ¯ÀÃºõ 120 Ôõ ºò¾¡ìÌõ. 
 ¸¡Ãò¨¾ì ¸ðÎõ. 
 ¸ªíÌ, ¦ºóàÃõ, ÌÕ ­¨Å¸ÙìÌ ¬¾¢Â¡Ìõ. 
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ºòÐÕ ºÃìÌ¸û : 
               º¢Ä¡ºòÐ, «ñ¼õ, Íñ½õ, âÃõ, Ý¼ý. 
                        «¸ò¾¢Â÷ ÀÃ¢âÃ½õ-1200 
 
Á¢òÐÕ ºÃìÌ¸û : 
 À¡¼¡½õ, ¯ÀÃºõ, ¯§Ä¡¸õ. 
 
¦Åí¸¡Ãò¾¢ý Í¨Å ÁüÚõ Å£Ã¢Âõ : 
Í¨Å : 
    ÐÅ÷ôÒ, ­É¢ôÒ¼ý ÜÊÂ ÐÅ÷ôÒ. 
 
Å£Ã¢Âõ : 
     ¦ÅôÀõ 
  
¦ºö¨¸ : 
       ¯ûª¡ðº¢: 
 Ìª¢÷îº¢ ¯ñ¼¡ì¸¢ 
 º¢Ú¿£÷ ¦ÀÕì¸¢ 
 ¸ø¸¨Ãîº¢                   
 À¢ÃºÅ¸¡Ã¢ 
 
¦Åª¢Â¡ðº¢ : 
 ºÁÉ¸¡Ã¢ 
 ¯¼ø§¾üÈ¢ 
 «Ø¸Ä¸üÈ¢ 
 ÐÅ÷ôÒ 
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¦À¡Ð Ì½õ : 
 
       
       ÀÈ¢¸¢Ã¸½¢ ¸øæÉõ Àñ§½¡õ - ¦¿È¢¨Âò 
       ¾¼í¸½í¸ Àí¸¢ÕÁ¢ º÷ôÀÅ¢¼í ºó¿¢ 
        
 
 ¦º¡È¢, Ò¨¼, ÌýÁõ, ¾¢É×, ­Ãò¾ ãÄõ, Àø§¿¡ö, ¿¡ªÅÆ¢¨Âò  
 ¾Îì¸¢ýÈ ãò¾¢Ã ¸¢Ã¢îºÃí¸û Ó¾Ä¢Â¨Å ¿£íÌõ. 
 
ÅÆìÌ Ó¨È¸û : 
 ¦À¡Ã¢ò¾ ¦Åí¸¡Ãò¨¾ 5 Ó¾ø 10 ÌýÈ¢  ­ª¿£Ã¢ø §À¡ðÎì 
¦¸¡Îì¸ ¿£÷ì¸ðÎ ¿£íÌõ. 
 ¦Åí¸¡Ã ¿£÷ : Å¡öôÒñ, ¦¾¡ñ¨¼ôÒñ, «ì¸Ãõ 
Ó¾Ä¢Â¨ÅìÌ Å¡ö ¦¸¡ôÒª¢ôÀ¾üÌ ÀÂýÀÎò¾Ä¡õ. 
 
§ºÕõ À¢È ÁÕóÐ¸û : 
¯û ÁÕóÐ¸û  
º¢ó¾¡Á½¢ì Ìª¢¨¸ : 
¾£Õõ §¿¡ö       :   ¿£÷ì¸ðÎ, ÁÄì¸ðÎ, «Æø §¿¡ö. 
 
¿Åì¸¢Ã¸ âÀ¾¢     : 
¾£Õõ §¿¡ö      : ¿£Ã¡õÀø, Åø¨Ä. 
 
º¢óÐ ÅøÄ¡¾¢ ¦ÁØÌ : 
¾£Õõ §¿¡ö      : ¿£Ã¨¼ôÒ, ¸øÄ¨¼ôÒ, «ñ¼Å¡ö×, º¨¾Â¨¼ôÒ, ¦ÀÕ  
                  ¿£÷ì§¸¡¨Å 
 
 
                        
                    
 
 
 
 
 
BOTANICAL REVIEW 
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4.2. BOTANICAL REVIEW 
 
1. Ficus glomerata roxb., 
Synonyms 
Ficus glomerata,  Ficus lucescens,  Ficus racemosavar.elongata. 
Common Name  
Udumbara, Gular fig, Cluster fig, Country fig, Cluster Fig Tree, Goolar Fig  
Vernacular name 
Tamil  :  Atti 
Hindi   :  Goolar 
 
Chemical constituents 
Major : Lupeol, Friodelin. 
Bark   Amyrin, Gluanol  Oac, B-SitosterolAnd A 
Ketone, Stigmatosterol. 
Leaves  Gluanol  Oac  Amyrin and -Sitosterol. 
Fruit - Lupeol-Oac, B-Sitosterol and A Sterol, tiglicacid, Ester of Taxaxasterol and 
Glucose. 
Uses 
 The root is useful in hydrophobia. Bark is cooling, acrid, galactogogue, good 
for gravid uterus. Unripe fruit is acrid and astringent to bowels, tonic, styptic, 
useful in kabam, biliousness, leucorrhoea and blood disorders. 
 Ripe fruit is acrid sweet, cooling, useful in blood disorders, burning 
sensation, urinary discharges, thirst, leprosy, menorrhagia, nose bleeding 
and intestinal worms. 
 Bark - useful in asthma and piles given as an astringent and as a wash for 
wounds. 
 Leaves - astringent to bowels and good for bronchitis. The fresh juice of the 
ripe fruit is used as an adjuvant to a metallic preparation which is given in 
diabetes and other urinary diseases. 
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2. Gossypim herbaceum.Linn 
 
Synonyms             :   Erioxylum Rose & Standl, Selera Ulbr, Ultragossypium  
                                           Roberty. 
Common name    :  Cotton plant. 
Vernacular name :   Karpash tula, Tula. 
Tamil  :  Paruthi 
Hindi   :  Kapas 
 
Botanical Classification 
Kingdom : Plantae  
Division :  Angiosperms  
Order  :  Malvales 
Family  :  Malvaceae 
Genus  :  Gossypium 
Species :   herbaecum 
 
Chemical constituents 
                    Gossypol, Gossyfulvin, Gossypurpurin, Gossycaeulin, Gossyoin, 
 Gossypetin, Gossypitrin ,Herbacetin, Herbacitrin, Lecuodelphinidine, Betine, 
Quercetin, Isoquercetin, Quercimeritrin, Phytosterols. 
 Root : Cycloartenol, Euphorbol, Teraxerone, Tinyatoxin.  
Properties 
                All parts are Cooling, Sweet, Acrid, Anti-dysenteric. 
Uses 
  Root decoction is given for Urinary problems. 
 Tincture of the fresh inner root bark is used to treat amenorrhea, 
dysmenorrhea.  
 Used to treat abscess of the labia. 
 The root is used to stop bleeding, especially internally. 
 Externally, used for rheumatism, a dressing for freckles, herpes, 
scabies,Neuralgia, chronic headache, ulcers, sores, swellings and 
wounds. 
 
 
 
 
 
MINERALOGICAL 
REVIEW 
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4.3. MINERALOGICAL REVIEW 
 
1. Karpoora silasathu: 
English :  Asphalt ; Mineral pitch ; Plaster of paris 
Hindi   :  Silajita  
 
Source 
               Ejected out of rocks during hot weather in the lower Himalayas, Vidhya and  
 other mountain tracts and Nepal where iron abounds, naturally flowing out from 
between  the fissures in the rocks or it may be a tar formed in the earth from the 
decomposition of  vegetable substances. 
 
Constituents 
                  Silasathu contains an oil which when distilled is known as ichthyol.  
Benzoic acid and benzoates which are present in silasathu in large quantities are 
considered by Chopra to be the main active principles. 
 
Action 
             Locally antiseptic, anodyne, parasiticide, and antiphlogistic. Internally 
diuretic, lithontriptic, alterative, tonic, slightly laxative, respiratory stimulant, 
expectorant, intestinal stimulant. 
                         
 Physical Properties of Gypsum (karpoora Silasathu)  
Lustre : 
            Vitreous, Silky, Dull 
Transparency : 
           Transparent, Opaque, Translucent 
Colour : 
            Colourless to white 
 
Tenacity : 
             Flexible 
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Uses: 
 It is specially employed in genito  urinary diseases and in diabetes. 
 It is mainly used  in Gall stones, Jaundice, Enlarged spleen, Anasarca, Renal 
stone and Bladder calculi, Anuria. 
 It is also used in Ascites, Uraemia. 
 Silasathu is used as an external application for inflammatory swellings, 
arthritis. 
 In strangury or painful micturation silasathu is used with other diuretic and  
demulcents. 
 
Supportive articles:  
 
1. The karpoora silasathu is one of the ingredients of the drug jalamanjari 
chendooram is an effective and significant hyponatraemic, hypochloraemic,   
hypokalaemic and diuretic activity is present. 
 
2. The karpoora silasathu is one of the ingredients of karasoodasathu parpam is 
indicated for urolithiasis and diuretic activity. 
 
 
3. The drug silasathu paavanai contains essential elements which are considered 
to be the inhibitors of stone formation. Moreover the drug has good anti 
microbial activity against E.coli which causes the commonest associated 
urinary tract infection.            
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 Crystallography of Gypsum (karpoora Silasathu) 
    
Crystal System : 
                      Monoclinic 
 
   Class : 
                    2 / m - Prismatic  
 
   Morphology :   
           
          Thin and thick tabular crystals.  
          Crystals may have wraped surfaces, or be bent or twisted. 
          Rosette  like clusters of lenticular crystals are common.               
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                                       4.3.2) BORAX (VENGARAM) 
 
Borax (sodium borate) is a naturally occurring mineral composed of sodium, boron,  
oxygen and water.  
Tam : Vengaram, Venkaram 
Eng : Sodium Biborate, Borax 
Sans : Tankana 
Tel : Velligaram 
Mal : Ponkaram 
 
SOURCE 
          It occurs as a natural deposit. Crude borax is found in masses by evaporation of 
water, on shores of dried up lakes in India and Tibet. 
 
Taste :             
             Sweet with astringent. 
 
Potency : 
            Heat 
 
Pirivu : 
          Pungent 
 
Action : 
       Diuretic 
       Astringent 
       Antacid 
       Local sedative 
       Anti-septic. 
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Physical Properties of Vengaram 
 
Chemical Formula : Na2B4O7 .10H2O 
Composition :  Hydrous sodium borate 
Colour :  Colourless, white, light grey.                            
  Also in light tints of blue, green and yellow.  
Streak   :  White 
Hardness :  2 - 2.5 
Transparency   :  Transparent to opaque 
Specific Gravity  :  1.7 
Luster   :  itreous to dull 
Other ID Marks :  1.Has a sweetish, metallic taste 
                            2 . Dissolve in water 
In Group :  Borates; Hydrous Borates 
 
Boraxs healing and preventative properties : 
 Borax protects against the accumulation of fluorides in the body; is 
effective as an antidote in fluoride toxicity; and can remove fluorides from 
the body. 
 Anti-microbial : 
Borax is toxic to insects, parasites, protozoa and bacteria. 
  Fungicide :  
          Effective against moulds and fungi, internally and externally.  
 Immune system enhancer : 
     Promotes healing of wounds. 
        Reduction and control of inflammation. 
 Toxin removal : 
        Protection from heavy metals. 
 Stabiliser of calcium, silicon, copper and magnesium levels, inhibits  
calcification. Boran sufficiency normalises calcium levels, preventing both 
abnormal  calcium deposition and bone weakness. 
 Obesity. 
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 Cancer. Boron may be a preventative for prostate cancer. 
 Antiseptic. Very effective for bladder infection and urinary tract 
infection. 
 
Uses : 
 Vengara parpam cures pitha disease like burning micturation and kalladaippu. 
Borax is given internally in doses varying from 10-30 grains in acidity of 
stomach, dyspepsia and intestinal organism. It commonly mixed in decoction 
for kalladaippu. 
 In small doses it is given to children as a laxative. 
It is also used in loss of appetite, painful dyspepsia, cough, asthma and 
diarrhoea. 
 Externally borax is used in lotion in acne, freckles, chloasma. 
 Boro-glycerine is useful as an antiseptic lotion in purulent ophthalmia and 
diphtheria. 
 
Supportive articles :  
 
1) The Vengaram is one of the ingredients of the drug jalamanjari chendooram 
is an effective and significant hyponatraemic, hypochloraemic,  hypokalaemic 
and diuretic activity is present.  
 
2) Toxicity study of Vengaram and Silasathu : 
  
              Acute oral toxicity study; NK and VSP at the dose of 2000mg/kg/po did not  
             exhibit any mortality in rats.  Repeated oral toxicity for 28 days; Test drug         
              NK and VSP at the dose 500mg/kg/po when administered for 28 days in rats       
              orally did not show toxicity in hematological parameter. 
 
 
 
 
 
 
 
 
 
 
ANALYTICAL STUDY 
OF 
THE DRUG 
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5. ANALYTICAL STUDY OF VELLAI PARPAM 
 
Analytical study of the drug brings the validation to be used as a medicine by 
subjecting the drug into many analysis and determining its quality and effectiveness.  
Characterization is essential to achieve analytical study of a drug. Through analytical 
studies such as screening of organoleptic analysis, physico chemical analysis and also 
to assess the active principles and elements present in the drug. Thus analytical study 
brings the efficacy and potency of the drug. Analytical study of the drug includes: 
 Organoleptic characters 
 Colour 
 Odour 
 Taste 
 
 Physicochemical analysis 
 Determination of Ash Values 
 Physical characterization 
 
 Chemical analysis 
 Preliminary Basic and Acidic radical studies  
 
 Heavy metal analysis      
 ICP OES 
 Analysis of partical size  
 SEM 
 
 5.1. ORGANOLEPTIC CHARACTER 
The organoleptic characters of the sample drug were evaluated. 1gm of the test drug 
was taken and the colour, texture, particle size and other morphology were viewed by 
naked eye under sunlight. Then the result was noted. 
 
 
 
 
 
 
 
PHYSICO CHEMICAL 
ANALYSIS 
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5.2. PHYSICOCHEMICAL ANALYSIS 
Physicochemical studies of the trial drug Vellai Parpam have been done 
according to the WHO guidelines. 
Determination of Ash Values 
Total Ash 
 
3g of the test drug was accurately weighed and incinerated in a crucible dish at 
a temperature not exceeding 450 ° C until it was free from carbon. It was then cooled 
and weighed. The % w/w of ash with reference to the air-dried powder was 
calculated. 
 
Water Soluble Ash 
The total ash was obtained as the above method for preparation of total ash. 
The ash was boiled with 25ml of water for 5mins. The insoluble ashes were collected 
using filter paper. It was then washed with hot water and transferred to the silica 
crucible. It was then ignited for 15minutes at temperature not exceeding 450oC. For 
determination of weight of the water soluble ash the silica crucible and residue were 
weighed until constant weight was attained. The weight of the water soluble ash is 
determined by subtracting the weight of insoluble ash from the weight of total ash. 
 
MATERIALS AND METHODS 
Acid insoluble Ash 
 
The total ash was obtained as the above method for preparation of total ash. 
The ash was boiled for 5minutes with 25ml 10% Hcl. The insoluble ashes were 
collected using filter paper and washed with hot water. It was then transferred to the 
silica crucible and ignited for 15minutes at temperature not exceeding 450oC. The 
silica crucible and residue were weighed until constant weight is attained. 
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Determination of Extractive Value 
Alcohol Soluble Extractive Value 
 
3g of test drug powder was weighed and macerated with 100ml of ethanol in a 
closed container for 24 hours. The resulting solution was shaken continuously for 6 
hours. It is then allowed to stand and soak for 18 hours. The solution was filtered and 
evaporated of the filtrate in a flat bottomed shallow dish and dried at 105oC. Then the 
content was cooled and weighed. 
 
Water soluble Extractive value 
3g of test drug powder was weighed and macerated with chloroform and water 
respectively, at 80oC for 24 hrs. The resulting solution was shaken continuously for 6 
hours and allowed to stand and soak for 24hrs then filtered. The solution from both 
chloroform and water respectively was filtered and evaporated of the filtrate in a flat 
bottomed shallow dish. It was dried at 105oC then cooled and weighed. 
 
Determination of Loss on Drying at 105°C 
The powdered drug was taken and dried in the oven at 105°C to constant 
weight. The result was noted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHEMICAL ANALYSIS 
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5.3 CHEMICAL ANALYSIS OF VELLAI PARPAM 
The chemical analysis of VELLAI PARPAM was carried out in Bio chemistry 
Lab, National institute of siddha. 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract Light white  in colour  
2. Test for Silicate 
a. A 500mg of the sample was shaken 
well with distilled water. 
 
Fully soluble. 
 
 
Absence of 
Silicate 
3. Action of Heat: 
A 500mg of the sample was taken in a 
dry test tube and heated gently at first 
and then strong. 
No white fumes 
evolved. 
No brown fumes 
evolved. 
 
Absence of 
Carbonate 
Absence of 
Nitrate. 
 
4. Flame Test: 
A 500mg of the sample was made into 
a paste with con. HCl in a watch glass 
and introduced into non-luminous part 
of the Bunsen flame. 
 
No bluish green 
flame 
 
 
Absence  of 
copper 
 
 
5. Ash Test: 
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited. 
 
Appearance of yellow 
colour flame 
 
 
 
 
Absence of 
sodium 
 
 
 
Preparation of Extract: 
5gm of Vellai Parpam was taken in a 250ml clean beaker and added with 50 ml of 
distilled water. Then it is boiled well for about 10 minutes. Then it is cooled and 
filtered in a 100ml volumetric flask and made up to 100ml with distilled water. This 
preparation is used for the qualitative analysis of acidic/basic radicals and 
biochemical constituents in it. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. 
 
 
 
Test For Sulphate: 
2 ml of the above prepared extract was 
taken in a test tube to this added 2ml of 
4% dil ammonium oxalate solution 
Cloudy appearance 
Presence. 
 
Presence of 
Sulphate 
 
2. 
Test For Chloride: 
2 ml of the above prepared extract was 
added with 2ml of dil-HCl is added until 
the effervescence ceases off. 
Cloudy appearance 
present. 
 
Presence of 
Chloride 
 
 
3. 
 
Test For Phosphate: 
2ml of the extract were treated with 2ml 
of dil. ammoniummolybdate solution 
and 2ml of con.Hno3 
No cloudy yellow 
appearance 
 
Presence of 
Phosphate 
 
4. 
 
Test For Carbonate: 
2ml of the extract was treated with 2ml 
dil. magnesium sulphate solution 
Cloudy appearance 
presence. 
 
Presence of  
carbonate 
 
 
5. 
 
Test For Nitrate: 
1gm of the extract was heated with 
copper turning and concentrated H2So4 
and viewed the test tube vertically 
down. 
No Brown gas is 
evolved 
 
 
Absence of 
nitrate 
 
 
6. 
Test For Sulphide: 
1gm of the extract was treated with 2ml 
of con. HCL 
No rotten egg 
smelling gas is 
evolved 
Absence of 
sulphide 
 
7. 
 
Test For Fluoride & Oxalate: 
2ml of extract was added with 2ml of 
dil. Acetic acid and 2ml dil.calcium 
chloride solution and heated. 
No cloudy 
appearance. 
 
Absence of 
fluoride and 
oxalate 
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8. 
 
Test For Nitrite: 
3drops of the extract was placed on a 
filter paper, on that-2 drops of dil.acetic 
acid and 2 drops of dil. benzidine 
solution is placed. 
No characteristic 
changes 
Absence of 
nitrite 
 
 
 
9. 
 
Test For Borate: 
2 Pinches (50mg) of the extract was 
made into paste by using dil.sulphuric 
acid and alcohol (95%) and introduced 
into the blue flame. 
Bluish green colour 
flame not appeared 
Absence of 
borate 
II. Test For Basic Radicals 
1. 
Test For Lead: 
2ml of the extract was added with 2ml of 
dil. potassium iodide solution. 
No Yellow 
precipitate is 
obtained 
 
Absence of  
lead 
 
2. 
Test For Copper: 
a. One pinch (25mg) of extract was made 
into paste with con. HCl in a watch glass 
and introduced into the non-luminuous part 
of the flame. 
No blue colour 
precipitate  
 
 
Absence of    
copper 
 
 
3. 
Test For Aluminium: 
To the 2ml of extract dil. sodium 
hydroxide was added in 5 drops. 
No characteristic 
changes  
 
Absence of    
Aluminium 
 
4. 
Test For Iron: 
 To the 2ml of extract add 2ml of dil. 
Ammonium thiocyanate solution. 
b. To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
No red colour 
appeared 
Absence of 
Iron 
5. 
Test For Zinc:  
To 2ml of the extract dil. sodium 
hydroxide solution was added in 5 drops to 
excess and dil. ammonium chloride is 
added.  
 
     No  white      
     precipitate 
 
 
 
Absence of 
Zinc 
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6. 
Test For Calcium:  
2ml of the extract was added with 2ml of 
4% dil. ammonium oxalate solution  
Cloudy appearance 
and white 
precipitate is 
obtained 
Presence of 
calcium 
 
7. 
Test For Magnesium:  
To 2ml of extract dil. sodium hydroxide 
solution was added in drops to excess. 
White precipitate is 
obtained 
 
Presence  of 
magnesium 
 
8. 
Test For Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent 
and excess of dil. sodium hydroxide 
solution were added. 
 No brown colour   
 
 
Absence  of 
ammonium 
 
9. 
Test For Potassium: 
A pinch (25mg) of extract was treated with 
2ml of dil. sodium nitrite solution and then 
treated with 2ml of dil. cobalt nitrate in 
30% dil. glacial acetic acid. 
No yellow 
precipitate is 
obtained 
 
Absence of 
potassium 
 
 
10. 
Test For Sodium: 
2 pinches (50mg) of the extract is made 
into paste by using HCl and introduced 
into the blue flame of Bunsen burner. 
 
 
No yellow colour 
flame evolved. 
 
Absence of 
sodium 
 
11. 
Test For Mercury:  
  2ml of the extract was treated with 2ml of 
dil. sodium hydroxide solution.  
 No yellow 
precipitate is 
obtained 
 
Absence of 
Mercury 
 
 
12. 
Test For Arsenic:  
   2ml of the extract was treated with 2ml 
of dil. sodium hydroxide solution. 
No  brownish red 
precipitate is 
obtained 
Absence of 
arsenic 
III. Miscellaneous 
1.
  
Test For Starch: 
2ml of extract was treated with weak dil. 
Iodine solution  
  No blue colour 
developed 
 
Absence of 
starch 
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2.
  
Test For Reducing Sugar: 
5ml of Benedict's qualitative solution was 
taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the 
extract and again boil it for 2 minutes. The 
colour changes were noted. 
  
No brick red colour 
is developed  
 
 
Absence of  
reducing 
sugar 
 
 
 
3. 
Test For The Alkaloids: 
2ml of the extract was treated with 2ml of 
dil. picric acid 
No yellow colour 
was developed 
Absence 
of Alkaloid 
 
 
4.
  
Test For Tannic Acid:  
2ml of extract was treated with 2ml of 
dil.ferric chloride solution  
 No Blue-black 
precipitate is 
obtained  
Absence of 
Tannic acid 
 
 
5.
  
Test For Unsaturated Compound: 
To the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added.  
Potassium 
permanganate is 
not decolourised 
  Absence of 
unsaturated 
compound 
6.
  
Test For Amino Acid: 
2 drops of the extract was placed on a filter 
paper and dried well. 20ml of Burette 
reagent is added. 
No violet colour 
 
Absence of 
amino acid 
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Test For Type Of Compound: 
2ml of the extract was treated with 2 ml of 
dil.ferric chloride solution 
No green colour 
was developed 
 
 
 
 
No red colour was 
developed 
 
 
 
 
No violet colour 
was developed 
 
 
 
 
No Blue colour 
was developed. 
Absence of 
oxyquinol 
epinephrine 
and 
pyrocatechol 
Antipyrine, 
Aliphatic 
amino acids 
and meconic 
acid are 
absent. 
Apomorphin
e  salicylate 
and 
Resorcinol 
are absent.  
Morphine, 
Phenol 
cresol and 
hydrouinone 
are absent. 
 
  
 
 
 
 
 
ELEMENTAL 
ANALYSIS 
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5.4. ELEMENTAL ANALYSIS: 
 
HEAVY METAL ANALYSIS 
 The analysis of heavy metals and trace elements were estimated by using 
Inductively coupled plasma optical emission spectrometry (ICP- OES). The 
Experimental Procedure was done at SAIF, IIT Madras, Chennai-36. 
ICP-OES INDUCTIVELY COUPLED PLASMA OPTICAL EMISSIOS 
SPECTROMETRY (ICP OES) 
 
Introduction 
  The element composition of a sample is often an important part of the 
information needed to assess its properties. Hence there is a need for scientific 
instrumentation like ICP-OES which plays a pivotal role in the determination of these 
elements. ICP-OES is widely employed for the estimation of metals and metallolids at 
trace, minor and major concentration. 
 
Principle  
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons. The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer , so that intension of the individual wavelength 
can be measured . The number of photos emitted is directly proportional to the 
concentration of the element.  The photos may be detected either sequentially or 
simultaneously. Quantitative analysis is achieved by measuring the intensity of these 
specific wavelength and after performing the calibration using known standards. 
Identifying the presence of emission at the wavelength characteristic of the element of 
interest obtaining quantitative information i.e, how much of an element is in sample 
can be accomplished using plots of emission intensity versus concentration called 
calibration curves. 
 
 
 
 
 
33 
 
 
Sample preparation  Microwave Digestion 
 Weight 0.25 g of test sample and transfer into a liner provided with instrument. 
 Slowly add 9ml of Nitric acid or sulphuric acid such that no piece of sample 
sticks on the slide. 
 Mix thoroughly and allow reacting for few minutes. 
 Place the liner in the vessel jacket. 
 Close the screw cap hand- tight in clockwise direction. 
 Seal the vessel and placed in the rotor fixed in microwave. 
 Set temperature to 180°C for 5 minutes, hold at 180°C  for least 10 minutes.                                                 
Allow the vessels to cool down to a vessel interior temperature below 60°C and 
to a vessel surface temperature (IR) below 50°C before removing the rotor. 
 The digested sample was made up to 100ml with Millipore water. If visible 
insoluble particles exist, solution could be filtered through whatmann filter 
paper. 
 Transfer the digested solution into plastic containers and label them properly. 
Perkin Elmer Optima 5300DV was used for standard ICP-OES analysis. The 
optimized operating conditions are given in table 1, the wavelength of analytical 
lines are given in table and the test Velai Parpam underwent microwave 
digestion for sample preparation.  
 
Table 1 : ICP- OES Operating Conditions 
 
Rf frequency 40 M Hz  
Range 165  782 nm 
Detection limit Up to ppm level using SCD detector 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANALYSIS OF  
PARTICLE SIZE 
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5.5 ANALYSIS OF PARTICAL SIZE 
 
SCANNED ELECTRON MICROSCOPY (SEM) 
The partical size of the Vellai Parpam was determined using High resolution 
scanning electron microscopy (HR SEM). The Experimental Procedure was done at 
SAIF, IIT Madras, Chennai-36. 
 
Experimental procedure : 
              A SEM is essentially a high magnification microscope, which uses a focused 
scanned electron beam to produce images of the sample, both top-down and, with the 
necessary sample preparation, cross-sections. The primary electron beam interacts 
with the sample in a number of key ways :- 
 Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen. 
 Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast. 
 Ionized atoms can relax by electron shell-to-shell transitions, which lead to 
either X-ray emission or Auger electron ejection. The X-ray emitted are 
characteristic of the elements in the top few µm of the sample. 
 
The SEM is carried out by using FEI Quanta FEG 200-High Resolution 
Instrument. 
Resolution   :   1.2 nm gold particle separation on a carbon substrate 
Magnification :   From a min of 12 X to greater than 1,00,000 X. 
 
Method : 
          A representative portion of each sample was sprinkled on to a double side 
carbon tape and mounted on aluminium stubs, in order to get a higher quality 
secondary electron image for SEM examination. 
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Sample preparation : 
       Sample preparation can be minimal or elaborate for SEM analysis, depending on 
the nature of the samples and the data required. Minimal preparation includes 
acquisition of a sample that will fit into the SEM chamber and some accommodation 
to prevent charge build-up on electrically insulating samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TOXICITY STUDIES 
 
 
 
 
 
 
 
 
 
 
 
ACUTE TOXICITY  
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6. TOXICOLOGICAL STUDY 
 
6.1. SAFETY AND PHARMACOLOGICAL PROFILE OF SIDDHA DRUG 
 
AIM vellai parpam acute 
toxicity studies in wistar rats 
 
Test drug: To Evaluate the acute and sub acute toxicities of siddha drug vellai 
parpam in wistar albino rats. 
 
Drug and preparation of stock solution 
The aqueous suspension of vellai parpam was prepared in 1% 
CarboxyMethylCellulose (CMC) solution in distilled water prior to oral 
administration to animals. It was used within seven days and stored at 8ºC .While for 
further use freshly prepared solution were used .The vehicle alone served as control. 
 
Experimental animals: 
Albino rats (wistar rats) of either sex, weighing (150-250 g) were procured 
from animal housing facility, K, K college of pharmacy, Gerugambakkam, Chennai. 
All animals were placed in a polypropylene cages in a controlled room temperature  
24ºC ±1ºC and relative humidity of 60-70 % in animal house. The animals were 
maintained in standard pellet diet and water ad libitum. They were acclimatized to 
laboratory condition for seven days before commencement of the experiment. 
All the protocols and the experiments conducted in strict compliance according to 
ethical principles and guidelines provided by committee for the purpose of control and 
Supervision of Experiments on Animals (KKCP/2015/4529). Animal 
experimentation protocols are approved by Institutional Animal Ethical Committee. 
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Acute oral toxicity study: 
        The Acute toxicity studies were performed in accordance with the OECD 423   
guidelines. Female wistar rats weighing 100-250gm were selected and divided into 5 
groups containing three animals in each group. The single dose of vellai parpam the 
dose starting from 5mg/kg up to 2000mg/kg (5, 50, 300, 2000mg/kg) was 
administered orally. The drug treated animals were carefully observed individually for 
the toxicity signs and mortality. The parameters such as changes in skin and fur, eyes 
and mucous membranes, respiratory, circulatory, autonomic and central nervous 
system, behavioural pattern, convulsions, tremors, salivation, lethargy, diarrhoea,  
sleep and coma were observed. From the maximum dose 1\5th or 1\10th of the dose 
was considered as therapeutic dose for further study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
REPEATED DOSE 28 
DAYS ORAL TOXICITY 
STUDY   
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6.2.  SUB ACUTE TOXICITY STUDIES OF VELLAI  PARPAM  IN WISTAR 
ALBINO RATS  -    (OECD  407 guidelines) 
Sub-acute toxicity studies were carried out according to OECD 407 and rats 
were divided into 3 groups of 10 animals (5 male and 5 female). Vellai Parpam was 
administered to rats at the dose of 200mg/kg and 400mg/kg for 28 days. The animals 
were observed daily for gross behavioural changes and other sign of sub acute 
toxicity. The weight of the each rat was recorded on day 0 and weekly throughout the 
course of the study, Food and water consumption per rat was calculated. At the end of 
28 days they were fasted overnight ,each animals were anaesthetized with diethyl 
ether and blood samples were collected from the retro-orbital plexus into two tubes: 
one with EDTA for immediate analysis of haematological parameters, the other 
without any anticoagulant and was centrifuged at 4000 rpm at 4°C for 10 minutes to 
obtain the serum. Serum was stored at 20°C until analyzed for biochemical 
parameters. 
Test Substance : Vellai Parpam 
Animal Source  : Animal house of King Institute of Preventive Medicine 
Animals : Male and Female Wistar Albino Rats  
Age  : More than 8 weeks 
Acclimatization : Seven days prior to dosing. 
Veterinary 
examination 
: Prior to and at the end of the acclimatization period. 
Identification of 
animals 
: By cage number, animal number and individual marking 
on fur. 
Diet : Pelleted feed supplied by Godrej foods Pvt Ltd, 
Bangalore 
Water  : Portable water in polypropylene bottles ad libitum. 
Housing & 
Environment 
: The animals were housed in Polypropylene cages 
provided with bedding of husk. 
Housing temperature : Between 20 & 24°C,  
Relative humidity : Between 30% and 70%, 
Dark and light cycle  : Each of 12 hours. 
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Justification for Dose Selection: 
The results of acute toxicity studies in rats indicated that Vellai Parpam was 
non toxic and no behavioural changes was observed up to the dose level of 
2000mg/kg body weight. The oral route was selected for use because oral route is 
considered to be a proposed therapeutic route. From the maximum dose 1\5th or 
1\10th of the dose was considered as therapeutic dose for further study. 
 
Preparation and administration of dose:  
Vellai Parpam at two doses level 36mg/kg and 360mg/kg respectively were 
prepared. The test substance was freshly prepared every 7 days for 28 days. The 
control animals were administered vehicle only. Administration was by oral (gavage), 
once daily for 28 consecutive days. 
 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
 The rats randomly divided into three groups. In each group contains 10 
animals. 
the initiation of treatment. Each animal was fur marked with picric acid. The females 
were nulliporous and non-pregnant. 
 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course of study for 
the following: 
i) Body Weight: 
Weight of each rat was recorded on day 0 and at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percent body weight gain were calculated. (table -9) 
ii) Food and water Consumption:  
The quantity of food consumed by groups consisting of ten animals of for 
different doses was recorded at weekly interval. Food consumed per animal was 
calculated for control and the treated dose groups.  
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iii) Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any were recorded. 
 iv) Mortality:  
All animals were observed twice daily for mortality during entire course of 
study. 
v) Laboratory investigation: 
Following laboratory investigations were carried out on day 29 in animals 
fasted over-night. On 29th day, the animals were fasted for approximately 18 hr, then 
anesthetized with ether and blood samples were collected from the retro-orbital plexus 
into two tubes: one with EDTA for immediate analysis of haematological parameters, 
the other without any anticoagulant and was centrifuged at 4000 rpm at 4°C for 10 
minutes to obtain the serum. Serum was stored at 20°C until analyzed for biochemical 
parameters. 
 
Haematological Investigations:  
Blood samples of control and experimental rats was analyzed for haemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count, 
Mean corpuscular volume (MCV) and packed cell volume (PCV). From the estimated 
values of RBC count (millions/mm3) and PCV (volumes percent), mean corpuscular 
volume (MCV) was calculated.  
 
Biochemical Investigations:  
Serum and Urine was used for the estimation of biochemical parameters. 
Samples of control and experimental rats were analyzed for protein, bilirubin, urea, 
uric acid, creatinine, triglyceride, cholesterol and glucose levels by using standard 
methods. Activities of glutamate oxaloacetate transaminase/ Aspartate amino 
transferase (GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase 
(GPT/ALT) and alkaline phosphatase were estimated as per the colorimetric 
procedure.  
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Necropsy: 
All the animals were sacrificed on day 29. Necropsy of all animals was carried 
out and the weights of the organs including liver, kidneys, spleen, heart, uterus and 
testes/ovaries were recorded. The relative organ weight of each animal was then 
calculated as follows; 
     
    Absolute organ weight (g)  
Relative organ weight = ____________________________________________ ×100 
    Body weight of rats on sacrifice day (g) 
 
Histopathology:  
Histopathological investigation of the vital organs was done. The organ pieces 
(3-5µm thick) of the highest dose level of 2000mg /kg were preserved and were fixed 
in 10% formalin for 24 h and washed in running water for 24 h. Samples were 
dehydrated in an auto technicon and then cleared in benzene to remove absolute 
alcohol.  Embedding was done by passing the cleared samples through three cups 
containing molten paraffin at 50°C and then in a cubical block of paraffin made by the 
Haematoxylin-eosin.   
The organs included heart, kidneys, liver, spleen and pancreas of the animals 
were preserved they were subjected to histopathological examination. 
 
Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, haematology and blood chemistry were subjected to One-way Anova 
Followed by Dunnet  
(Graph Pad Prism 5.0) 
 
 
 
 
 
 
 
 
 
 
 
 
REPEATED DOSE 90 
DAYS ORAL TOXICITY 
STUDY  
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6.3. REPEATED DOSE 90-DAYS ORAL TOXICITY STUDY OF 
VELLAI PARPAM IN WISTAR ALBINO RATS (OECD GUIDELINE - 408) 
 
Test Substance  
IAEC Number             
 
           
   :   Vellai Parpam 
:  NIS/IAEC - II/2016/07. 
Animal Source  : King institute of technology, Guindy, Chennai.   
Animals   : Wister Albino Rats (Male -12, and Female-12) 
Age    : 6-8 weeks 
Body Weight               : 150-200gm. 
Acclimatization  : Seven days prior to dosing. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual   
                                                  marking by using Picric acid. 
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,       
                  Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
       provided with bedding of husk. 
Housing temperature :  between 22ºC + 3ºC.    
Relative humidity  :  between 30% and 70%, 
Air changes    : 10 to 15 per hour  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 90 Days. 
 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
24 Wistar Albino Rats (12M + 12F) were selected and divided into 4 groups. 
Each group consist of 6 animals (Male -3, and Female-3). Ist group treated as a 
control and other three group were treated with test drug (low, mid, high) for 90 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior 
to the initiation of treatment. Each animal was marked with picric acid. The females 
were nulliparous and non-pregnant. 
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Justification for Dose Selection: 
         As per OECD guideline three dose levels were selected for the study.They are 
low dose (X), mid dose dose (5X), high dose (10X). X is calculated by multiplying 
the therapeutic dose (400 mg) and the body surface area of the rat (0.018). i.e X 
dose is 7.2 mg/animal, 5X dose is 36 mg/animal,10X dose is 72 mg/animal. 
 
Preparation and Administration of Dose: 
VELLAI PARPAM was suspended in Honey with distilled water to obtain 
concentrations of 200mg/ml. It was administered to animals at the dose levels of X, 
5X, 10X. The test substance suspensions were freshly prepared every two days once 
for 90 days. The control animals were administered vehicle only. The drug was 
administered orally by using oral gavage once daily for 90 consecutive days. 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course 
of study for the following: 
 Body Weight: 
 Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study. 
 Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
 Mortality: 
All animals were observed twice daily for mortality during entire course of   
study. 
 Laboratory Investigations: 
             Following laboratory investigations were carried out on day 91 in 
s fasted over-night. Blood samples were collected from orbital sinus 
using sodium heparin (200IU/ml) for Bio chemistry and potassium EDTA (1.5 
mg/ml) for Haematology as anticoagulant. Blood samples were centrifuged at 
3000 r.p.m. for 10 minutes. 
 Haematological Investigations: 
               Haematological parameters were determined using Haematology 
analyzer.  
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 Biochemical Investigations:  
              Biochemical parameters were determined using auto-analyzer. 
 
  Histopathology:  
              Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose 
group than the low, then the mid dose group will also be examined. Organs will be 
collected from all animals and preserved in 10% buffered neutral formalin for  
24 h and washed in running water for 24 h.  The organ sliced 5 or 6µm sections 
and were dehydrated in an auto technicon and then cleared in benzene to remove 
absolute alcohol. Embedding was done by passing the cleared samples through 
three cups containing molten paraffin at 50°C and then in a cubical block of 
were stained with Haematoxylin-eosin. 
 
 Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, haematology and blood chemistry were subjected to One-way  
test using a computer software programme -
INSTAT-V3 version. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PHARMACOLOGICAL 
STUDIES 
 
 
 
 
 
 
 
 
 
 
ANTI UROLITHIATIC 
ACTIVITY 
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            7. PHARMACOLOGICAL STUDY OF VELLAI PARPAM  
                                ON WISTAR ALBINO RATS 
 
7.1. ANTI UROLITHIATIC ACTIVITY 
 
Stone induction  Kidney stones were induced by 0.75% of ethylene glycol in 
drinking  water  for 28 days ad libitum. After 28 days induction, the animals were 
used for the study 
Table 2: Experimental design: 
 
In the experiment a total of 24 rats (6 normal rats, 18 urolithic rats) were used. 
The rats were divided into 4 groups of 6 rats each. Group I (Gr I)-Normal control rats; 
Group II (Gr II)-Urolithic rats, (Gr III)-Urolithic rats given Vellai Parpam (200mg/kg 
for 28 days) and (Gr IV)-Urolithic rats given Vellai Parpam (400mg/kg for 28 days). 
At the end of 28 days, the animals were housed in metabolic cages and collected urine 
after 24 h.  
 
Biochemical assays 
The urine collected after 24 h was subjected to analyze calcium, oxalate, uric 
acid, citrate.  
 
 
 
 
Groups Treatment 
Group I Normal Control 
Group II Urolithiatic rats- 0.75% of ethylene glycol 
for 28 days 
Group III Urolithiatic rats +   Vellai Parpam 
200mg/kg for 28 days 
Group V Urolithiatic rats +   Vellai Parpam 
400mg/kg for 28 days 
 
 
 
 
 
 
DIURETIC ACTIVITY 
 
 
 
 
 
 
46 
 
7.2. Diuretic Activity On Wister Albino Rats (Lipschitz Method) 
 
Wistar rats were divided into five groups of six rats in the group (I) served as 
normal control (Vehicle) which received normal saline water (2 ml/kg orally) only. 
Group II received as furosemide (10mg/kg, p.o) Groups (III) to (IV) received Vellai 
Parpam respectively at dose of 200 mg/kg and 400 mg/kg orally and immediately 
after the extract treatment, all the rats are hydrated with saline (15 ml/kg) and placed 
in a metabolic cages. A total volume of urine collected for 5 hr was measured at the 
end. During this period no food and water were made available to animals. Various 
parameters like total urine volume and concentration of sodium, potassium and 
chloride in the urine were measured and estimated respectively. 
 
Estimation Of Urinary Electrolytes 
 
Urine electrolytes (Na, K and Cl-) were determined by Ion selective Electrode 
method as described by the user instruction manual of the biochemical kits (Roche, 
Roche diagnostics Pvt. Ltd.,) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANTI-INFLAMMATORY 
ACTIVITY 
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7.3. Anti  Inflammatory Activity On Wistar Albino Rats  
(Carrageenan-Induced Rat Paw Edema) 
 
The extract of Vellai Parpam (200 and 400 mg/kg) or indomethacin (10 
induced half an hour after above treatment by sub-planter injection of 0.1 ml freshly 
prepared 1% suspension of carrageenan in right hind paw in rats (Winter et al., 1962). 
The paw volume was measured initially and then at 1, 2, 3and 4 h after the 
carrageenan injection by using plethysmographic method of Harris and Spencer 
(1962). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
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                                            8. RESULTS  
 
  Many studies have been carried out to bring the efficacy and potency of the 
drug Vellai Parpam. The study includes literary collections, organoleptic character, 
physicochemical, Chemical analysis, Elemental analysis and toxicological study and 
pharmacological study. The drug Vellai Parpam has been selected from the text 
Agathiyar vaithiya kaaviyam 1500  
 
 Botanical aspect explains the active principle and medicinal uses of the 
plants. 
 Gunapadam review brings the effectiveness of the drug in treating renal 
stone. 
 The pharmacological review explains about the methodology of Anti-
Urolithiatic 
 Activity and the drugs used. 
 Modern and siddha aspect of the disease was also reviewed. 
 
 
4. ANALYTICAL STUDY OF THE TEST DRUG 
 Analytical study of the drug is more essential to derive the efficacy, potency 
of the drug by analysing it by various studies. Following are the results of 
physicochemical and Chemical analysis. Physical characterisation and estimation 
of basic and acidic radicals have been done and tabulated. 
 
Toxicological results of the drug and pharmacological activity of the drug 
were derived. Its result has been tabulated and interpretation was made below. 
Thus it is to give a complete justification to bring the effectiveness of the trial 
drug Vellai Parpam. 
 
 
 
 
 
 
49 
 
 
5.1. ORGANOLEPTIC CHARACTER 
             The following characters have been noted in Vellai Parpam 
                                               Table 3:  organoleptic characters 
      Colour         White 
      Odour        Pleasant  
      Taste        Characteristic taste 
      Texture       Fine powder 
      Particle size 
     Completely pass through         
      sieve no 120 
 
5.2. PHYSICOCHEMICAL ANALYSIS  
Determination of Ash Values 
Table 4:  Percentage of Total Ash 
   
                        Parameter 
 
                            Percentage% 
 
                            Ash Value 
 
                                90.94 
 
Table 5:   Percentage of Acid insoluble ash values 
   
                        Parameter 
 
                            Percentage% 
 
                           Acid insoluble Ash 
 
                           20.78 
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Interpretation for ash values 
Ash: Ash constitutes the inorganic residues obtained after complete 
combustion of a drug. Thus Ash value is a validity parameter describe and to assess 
the degree of purity of a given drug. Total ash: Total ash value of herbo mineral drug 
indicated the amount of minerals and earthy materials present in the plant material. 
The total inorganic content (potassium, calcium, chloride, magnesium, etc.,) present 
in the drug is measured through the total ash value and it is of 90.94 % for Vellai 
Parpam. 
  
Acid insoluble ash: The acid insoluble ash value of the drug is 20.78% for 
Vellai Parpam. 
 
Loss on Drying 
Table 6: Percentage Loss in weight on drying 
 
Parameter 
 
Percentage% 
Loss on drying at 1050C 0.49 
 
 
INTERPRETATION 
 The total of volatile content and moisture present in the drug was established 
in loss on drying.  
 Moisture content of the drug reveals the stability and its shelf-life.  
 High moisture content can adversely affect the active ingredient of the drug.  
 Thus low moisture content could get maximum stability and better shelf life. 
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5.3. Results of acid radicals studies: 
Table 7:  Results of acid radicals studies: 
S.NO Parameter Observation Result 
1 Test for Sulphate Cloudy appearance 
present 
Positive 
2 Test for Chloride 
 
Cloudy appearance 
present 
 
Positive 
3 Test For Phosphate 
 
 
                  - 
 
Negative 
4 Test For Carbonate   
 
Cloudy appearance 
present 
 
Positive                                                   
 
5 Test For Nitrate 
 
 
                    - 
Negative 
6  Test for Sulphide  
                     - 
Negative 
7 Test For Fluoride &oxalate 
 
 
                     - 
Negative 
8 Test For Nitrite                      - 
 
Negative 
9 Test For Borax                      - Negative 
 
Interpretation 
The acidic radicals test shows the presence of Sulphate, Chloride, Carbonate .  
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Table 8: Results Of Basic Radicals Studies: 
S.NO Parameters Observation Result 
1 Test for Lead                     - Negative 
2 Test for Copper                      - Negative 
3 Test For Aluminium                      - Negative 
4 Test For Iron                      - Negative 
5 Test For Zinc                      - Negative 
6 Test for Calcium Cloudy appearance and  
  white precipitate is   
   obtained 
Positive 
7 Test For Magnesium   White precipitate is       
        Obtained 
Positive 
8 Test For Ammonium                                                  
                    - 
Negative 
 
9 Test For Potassium Yellowish precipitate is      
        Obtained 
Positive 
10  Test For Sodium  
                  - 
Negative 
11 Test For Mercury  
                  - 
Negative 
12 Test For Arsenic  
- 
Negative 
 
Interpretation : 
The basic radical test shows the presence of Calcium, Magnesium, Potassium and 
absence of heavy metals such as lead, arsenic and mercury.                                                                                    
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5.4. ELEMENTAL ANALYSIS: 
 INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROSCOPY  
Table 9: ICP OES Study results of Vellai Parpam 
S.NO               Elements Wavelength in nm Vellai Parpam mg 
/L 
1         Arsenic     As 188.979       BDL 
2         Calcium    Ca 315.807      222.370 
3         Cadmium    Cd 228.802      BDL 
4         Copper    Cu 327.393      BDL 
5         Nickel    Ni 231.604      BDL 
6         Mercury    Hg 253.653      BDL 
7        Sodium    Na 589.592      404.310 
8        Phosphorus    P 213.617      04.301 
9        Sulphur   S 181.975      21.824 
10        Lead   Pb 220.353      BDL 
  
*  BDL  Below Detection Limit  
 
       The results Shows the quantitative analysis of the elements present in Vellai 
Parpam. The heavy metals were found to be within normal limits. The presence of 
other elements shows the therapeutic value of Vellai Parpam. Hence the drug Vellai 
Parpam is considered as a safe drug. 
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5.5. ANALYSIS OF PARTICAL SIZE 
 
   SCANNED ELECTRON MICROSCOPY 
 
   Determination of Partical size of Vellai Parpam 
 
 
 
 
The picture shows that the particles are stabilize, have irregular morphology 
and distributed in near nano range, Vellai Parpam has particle size of 5 to 10 microns. 
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                       6. TOXICITY STUDY ON VELLAI PARPAM IN  
                                           WISTAR ALBINO RATS             
6.1. Acute oral toxicity study of VELLAI PARPAM   
Table 10: Dose finding experiment and its behavioural Signs of Toxicity 
 
No Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 5 + - - + - + - - - - - - - - - - - - - - 
2 50 + - - + - + - - - - - - - - - - - - - - 
3 300 + - - + - + - - - - - - - - - - - - - - 
4 2000 + - - + - + - - - - - - - - - - - - - - 
 
1.Alertness 2.Aggressiveness 3.Pile erection 4.Grooming 5.Gripping 6.Touch 
Response 7.Decreased Motor activity 8.Tremors 9.Convulsions 10.Muscle Spasm 
11.catatonia 12.Muscle relaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 
16.Exophthalmos 17.Diarrhoea 18. Writhing 19.Respiration 20.Mortality 
 
 
Interpretation: 
       
         The acute toxicity result shows no mortality rate up to 2000mg/kg. It showed 
changes in alertness, pile erection, grooming, touch response and decreased motor 
activity. The behavioral changes are normal. Hence the test drug Vellai Parpam is a 
safe herbal drug and can be used for long time administration 
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6.2. SUB-ACUTE ORAL TOXICITY 
REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY IN 
WISTAR ALBINO RATS 
Table 11:Body weight (g) of albino rats exposed to vellai parpam for 28 days 
 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
 
 
Chart 1:The mean weight of control and treated groups of wistar albino rat  
exposed to Vellai Parapm. 
 
 
0
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80
100
120
140
160
180
200
Control
Mid dose
High dose
1 Day
7 Days
14 Days
21 Days
28 Days
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 153.6±22.683  169.4±29.315 170.8±28.870 172.8 ± 29.73 175.8±28.310 
LOW DOSE 150.1 ±20.105 159.9 ± 20.88 161.5±21.706 159 ± 20.77 165.7 ± 12.83 
HIGH 
DOSE 
169.5± 28.75 181.7 ± 33.87 185.8 ± 32.48 192 ± 30.93 198 ± 26.74 
P value (p)* 
NS NS NS NS NS 
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Table 12: Water intake (ml/day) of Wistar albino rats group exposed to Vellai 
Parapm 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 61.5 ± 8.95 61.2±6.23 58.5±6.23 60±8.096 61.5±4.56 
MID DOSE  57.1±3.41 58.5±3.62 59.8±4.26 60.4±4.29 58.8±4.13 
HIGH DOSE 58±2.44 58.2±2.14 58.9±2.13 58.2±2.82 58.9±2.96 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA  
 
 
Chart 2: The average water intake of control and treated groups of wistar 
albino rat exposed to Vellai Parapm. 
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Table 13: Food intake (gms/day) of Wistar albino rats group exposed to Vellai     
                 Parapm.  
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 37±5.37 38.5±4.11 39.5±4.37 38.5±3.37 37±4.21 
MID DOSE 34.7±2.98 35.4±2.24 35.1±2.28 35.2±3.32 35.9±2.51 
HIGH DOSE 40.2±3.45 40.3±3.88 39.9±3.78 40.3±3.40 40.1±3.84 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA  
 
Chart 3: The average food intake of control and treated groups of wistar albino 
rat exposed to Vellai Parapm. 
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Table 14: Haematological parameters of Wistar albino rats group exposed to 
Vellai Parpam  
 
Haematological parameters Control Mid dose High dose 
    Total R.B.C. count   
(×106mm 3). 
9.09±0.03 9.12±0.03 9.09±0.3 
Total W.B.C. Count 
(×103 mm 3). 
12.37±0.23 12.38±0.16 12.36±0.14 
Haemoglobin (Hb) (g/dl) 15.42±0.24 15.45±0.17 15.35±0.17 
Hematocrit (%). 42.52±1.52 42.19± 1.76 42.39±1.61 
Platelets (×103 mm 3). 830.44±5.93 827.61±14.38 825.93±13.48 
Lymphocytes(%). 84.21±0.40 82.96±1.50 82.30±1.01 
Neutrophils (%). 20.23±1.35 19.23±0.59 18.83±0.45 
PCV 37.61±0.01 37.83±0.05 37.80±0.10 
MCV 52.13±0.23 52.36±0.33 52.46±0.33 
 
Data are expressed as mean ± SEM 
 
 
 
 
 
 
 
 
 
60 
 
Chart 4: The mean value of T.WBC of control and treated groups of wistar 
albino rats exposed to Vellai Parpam 
 
 
Chart 5: The mean value of Hb and T.RBC of control and treated groups of 
wistar albino rats exposed to Vellai Parpam 
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Chart 6: The mean value of Platelet of control and treated groups of wistar 
albino rats exposed to Vellai Parpam 
 
 
Chart 7: The mean value of Neutrophils and Lymphocytes of control and treated 
groups of wistar albino rats exposed to Vellai Parpam 
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Chart 8: The mean value of Monocytes, Basophils and Eosinophils of control and 
treated groups of wistar albino rats exposed to Vellai Parpam 
 
 
Chart 9: The mean value of PCV, MCHC and MCV of control and treated 
groups of wistar albino rats exposed to Vellai Parpam 
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Table 15: Biochemical Parameters of of Wistar albino rats group exposed Vellai 
Parpam  
BIOCHEMICAL 
PARAMETERS 
control Mid dose High dose 
P 
Value 
(p)* 
GLUCOSE (R) (mg/dl) 110.83±0.98 111.83±0.40 112.06±0.16 N.S 
T.CHOLESTROL(mg/dl) 92.45±1.36 92.38±1.68 89.42±4.12 N.S 
TGL(mg/dl) 47.31±3.15 45.08±2.23 46.83±2.33 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
 
Chart 10:  The mean value of Blood glucose, Total cholesterol and Triglycerides 
of control and treated groups of wistar albino rats exposed to vellai parpam 
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Table 16: Renal function test of of Wistar albino rats group exposed to Vellai 
Parpam 
PARAMETERS CONTROL Mid dose High dose 
P Value 
(p)* 
UREA (mg/dl) 15.30±0.47 14.00±0.45 13.9±1.258 N.S 
CREATININE(mg/dl) 0.5890±0.079 0.63±0.04 0.684±0.11 N.S 
URIC ACID (mg/dl) 1.2±0.01 1.2±0.02 1.2±0.02 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D (One 
         
Chart 11: The mean value of Urea, Creatinine and Uric acid of control and 
treated groups of wistar albino rats exposed to Vellai Parpam 
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Table 17: Liver Function Test of of Wistar albino rats group exposed to Vellai 
Parpam  
PARAMETERS CONTROL Mid dose High dose 
P 
Value 
(p)*  
T.BILIRUBIN(mg/dl) 0.2569±0.32 0.254±0.69 0.254±0.969 N.S 
AST(U/dl) 121.41±2.68 119.56±1.33 119.61±3.123 N.S 
ALT(IU/dl) 69.40±1.57 69.712±2.121 69.72±1.35 N.S 
ALP (IU/L) 112.6±4.67 115.01±1.029 116.41±4.154 N.S 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One 
 
 
Chart 12: The mean value of Total bilirubin of control and treated groups of 
wistar albino rats exposed to Vellai Parpam 
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Chart 13: The mean value of AST, ALT and ALP of control and treated groups 
of wistar albino rats exposed to Vellai Parpam 
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Interpretation  of Repeated dose 28 days oral toxicity study: 
 
Sub-acute oral toxicity study repeated dose of Vellai Parpam on rats were 
conducted. All animals from the treated dose survived throughout the dosing period of 
28 days. Various parameters were studied and the interpretation of the study result is 
discussed below. 
 
Body weight: 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited overall mild weight gain throughout the dosing period 
of 28 days. The quantity of food taken by the animals from different dose groups and 
the control is comparably normal. 
 
Interpretation of haematological investigation  
The haematological investigation results of the rats conducted on 28th day 
after the repeated dose of the drug revealed the values of different parameters. The 
increase and decrease in the values obtained were all within the normal biological and 
laboratory limits. 
 
Interpretation of biochemical investigation  
The biochemical investigations were conducted on 28th day and the result is 
produced. The results revealed there is no significant changes in the values of 
different parameters with that of the control. All the values were within the normal 
biological and laboratory limits. 
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  HISTOPATHOLOGICAL EXAMINATION    
                          
                 28-Days Repeated Dose Oral Toxicity Study Of Vellai Parpam In 
Wistar Albino Rats 
                                                              BRAIN                                                                                       
                                        
      
 CONTROL      HIGH DOSE 
 
 
HEART 
                        
 
 
 
 
 
 
 
CONTROL                 HIGH DOSE 
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                                                               KIDNEY 
 
                             
CONTROL      HIGH DOSE 
                                                              
                                                                     LIVER 
 
                           
CONTROL      HIGH DOSE 
                                             
Interpretation: 
The above slides show the histopathology studies of sub-acute toxicity. There is no 
toxicological abnormality seen in the vital organs after administration of the test drug 
Vellai Parpam. Thus the safety of the drug is revealed so that it can be administered 
for long time without any side effects.  
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REPEATED DOSE 90 DAYS ORAL TOXICITY STUDY OF 
VELLAI PARPAM IN WISTAR ALBINO RATS. 
 
Table 18: Sub chronic toxicity study - Body weight of wistar albino rats group     
                exposed to Vellai Parpam  
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 6 values are mean ± S.D (One 
way  
 
 
 
 
 
 
 
 
 
 
 
 
DAYS 
Weight(gms)/Days  
P value (p)* Control Low dose Mid dose High dose 
1 162.4±29.65 154.4 ± 21.83 155.6± 13.09 161.5± 28.17 NS 
15 170.1 ± 28.49 162.8 ± 23.54 171.7 ± 29.83 179.8 ± 32.13 NS 
30 184.4 ± 28.83 184.71 ± 14.76 182.8 ± 32.17 190.2 ± 28.55 NS 
45 202.7± 27.81 205.6± 29.12 203.1± 19.07 207.9± 22.05 NS 
60 226.6±33.47  232.6±23.91 230.6±33.61  226.6±23.63  NS 
75 240.8 ± 26.76 244.8 ± 28.08 242.0± 28.70 240.8 ±26.87 NS 
90 263.5± 27.94 266.9± 27.68 268.2± 27.31 266.1± 29.41 NS 
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Table 19: Haematological parameters of Wistar albino rats group exposed to 
Vellai Parapm. 
 
Category Control Low dose Mid dose High dose P value 
(p)* 
Total RBC 
cells/cu.mm) 
7.27±0.25 7.25±0.34 7.22±0.46 7.22±0.25 N.S 
Total WBC 
(cells/cu.mm) 
11316.67±29 11033.33±51 11050±70 11366.67±87 N.S 
Platelets 
cells/ul 
3.33±0.19 3.52±0.33 3.78±0.35 3.45±0.65 N.S 
Hb g/dl 12.75±0.33 12.56±0.30 13.51±0.78 12.81±1.30 N.S 
PCV% 38.27±1.0 37.69±0.91 39.9±2.3 38.46±0.08 N.S 
MCV fl 0.17±0.04 0.34±0.09 0.48±0.12 0.28±2.8 N.S 
MCH pg 32.50±1.37 33.00±1.6 30.33±2.2 30.17±3.2 N.S 
MCHC % 32.50±1.37 36.50±4.76 34.33±2.58 33.50±1.87 N.S 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 6 values are mean ± S.D (One way 
ANOVA  
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Chart 14: The mean value of T.WBC of control and treated groups of wistar 
albino rats exposed to Vellai Parapm 
 
 
 
Chart 15: The mean value of Hb and T.RBC of control and treated groups of 
wistar albino rats exposed to Vellai Parpam 
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Chart 16:The mean value of  Platelet of control and treated groups of wistar 
albino rats exposed to Vellai Parpam 
 
 
Chart 17:  The mean value of PCV, MCH, MCHC, MCV of control and treated 
groups of wistar albino rats exposed to Vellai Parpam
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Table 20: Biochemical Parameters of of Wistar albino rats group 
exposed to Vellai Parpam. 
BIOCHEMICAL 
PARAMETERS 
CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
GLUCOSE (R) (mg/dl) 121.67±5.6 122.37±10.1 121.33±10.8 120.97±11.8 N.S 
T.CHOLOSTEROL(mg/dl) 105.17±11.89 120.00±4.73 110.50±6.50 119.67±8.52 N.S 
HDL(mg/dl) 43.50±3.33 40.83±5.34 44.67±2.73 40.50±1.64 N.S 
LDL(mg/dl) 42±10.7 52.17±10.8 38.67±5.95 42±11.3 N.S 
VLDL(mg/dl) 29.60±1.85 26.93±3.77 27.20±1.67 23.30±2.32 N.S 
TRIGLY(mg/dl) 148.00±9.25 134.67±18.85 136±8.36 116.50±11.6 N.S 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 6 values are mean ± S.D (One way 
ANOVA  
 
Chart 18:The mean value of Total cholesterol and Triglycerides of control and 
treated groups of wistar albino rats exposed to Vellai Parpam
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Chart 19: The mean value of Blood sugar of control and treated groups of wistar 
albino rats exposed to Vellai Parpam
 
 
Chart 20: The mean value of HDL, LDL, VLDL of control and treated groups of 
wistar albino rats exposed to Vellai Parpam 
 
 
 
 
120
120.5
121
121.5
122
122.5
Control
low dose
Mid dose
High dose
B.glu
B.glu
0
10
20
30
40
50
60
Control
low dose
Mid dose
High dose
HDL
LDL
VLDL
 
76 
 
Table 21: Renal function test of of Wistar albino rats group exposed to Vellai 
Parpam 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
UREA (mg/dl) 28.33±5.2 31.50±4.23 29.17±4.30 31.67±5.82 N.S 
CREATININE(mg/d
l) 
0.567±0.13 0.517±0.172 0.550±0.137 0.483±0.116 N.S 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 6 values are mean ± S.D (One 
way ANOVA  
 
Chart 21:  The mean value of Urea and Creatinine of control and treated groups 
of  wistar albino rats exposed to Vellai Parpam 
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Table 22: Liver Function Test of  Wistar albino rats group exposed to Vellai 
Parpam  
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)*  
T.BILIRUBIN(mg/dl) 0.683±0.14 0.800±0.08 0.500±0.632 0.683±0.147 N.S 
SGOT(U/dl) 21.33±5.12 31.33±3.20 24.83±3.48 26.00±4.38 N.S 
SGPT(U/dl) 26.33±7.09 23.33±3.20 26.33±3.77 23.17±4.62 N.S 
ALP(U/dl) 72.33±21.3 65.33±16.56 77.33±19.0 83.83±19.77 N.S 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 6 values are mean ± S.D (One way 
ANOVA  
 
22: The mean value of SGOT, SGPT, ALP of control and treated groups of 
wistar albino rats exposed to Vellai Parpam 
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23: The mean value of T.bilirubin of control and treated groups of wistar albino  
       rats exposed to Vellai Parpam 
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Interpretation of repeated dose 90 days oral toxicity study: 
 
Repeated dose 90 days oral toxicity study of Vellai Parpam on rats were 
conducted. All animals from the treated dose survived throughout the dosing period of 
90 days. Various parameters were studied and the interpretation of the study result is 
discussed below. 
 
Body weight: 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited overall mild weight gain throughout the dosing period 
of 90 days. The quantity of food taken by the animals from different dose groups and 
the control is comparably normal. 
 
Interpretation of haematological investigation  
The haematological investigation results of the rats conducted on 90th day 
after the repeated dose of the drug revealed the values of different parameters. The 
increase and decrease in the values obtained were all within the normal biological and 
laboratory limits. 
 
Interpretation of biochemical investigation  
The biochemical investigations were conducted on 90th day and the result is   
produced. The results revealed there are no significant changes in the values of 
different parameters with that of the control. All the values were within the normal 
biological and laboratory limits. 
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  HISTOPATHOLOGICAL EXAMINATION       
                       
    Repeated Dose 90-Days Oral Toxicity Study Of Vellai Parpam In Wistar 
Albino Rats showing histopathologic slides of sub-chronic toxicity of Vellai 
Parpam 
 
HEART 
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showing histopathologic slides of repeated dose 90 days oral toxicity of Vellai 
Parpam 
KIDNEY 
       
            
CONTROL                                             HIGH DOSE 
 
SPLEEN 
 
 
         
 
 
 
 
 
 
CONTROL                                             HIGH DOSE 
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Interpretation: 
 
Kidney 
 Renal sections of both the samples exhibited normal histology with distinct 
cytoarchitecture in both the cortex and medulla 
 Appearance of glomeruli, tubules, interstitium and lumen was normal in both 
the samples with no signs of degeneration  
Heart 
 Regular arrangement of myocardial fibers with clear transverse striation and 
normal structure were observed. 
 Appearance of cardiomyocyte was normal with dark nuclear region. The 
nuclei of muscle fibers appear central arrangement. 
Liver 
 Appearance of portal vein, bile duct and hepatic artery was normal 
 Hepatocellular architecture, including hepatic sinusoid and hepatic cord was 
normal 
Spleen  
 Lymphoid follicles appears normal  
 Marginal sinus (MS) of the rat and its sinus lining cells appears normal 
 Erythropoietic cells (EP) are scattered throughout the red pulp of both the 
samples. 
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PHARMACOLOGICAL RESULTS 
1. Urolithiatic activity 
Table 23:  Effect of Vellai Parpam on ethylene glycol induced urolithiatic activity 
in rats 
  
Biochemical 
Assays 
Gr-I Gr-II Gr-III Gr-IV 
Calcium 0.82±0.07 2.66±0.15a 1.60±0.14b *** 1.14±0.08 b 
*** 
Oxalate 0.62±0.08 4.50±0.64 a 2.70±0.50  b * 2.05±0.06 b ** 
Uric acid 0.82±0.04 2.75±0.30 a 2.20±0.37 a* 1.42±0.25 b * 
Citrate 2.42±0.20 0.76±0.05 a 1.27±0.14 a*** 0.97±0.08a*** 
 
Calcium, oxalate, citrate, uric acid, mg/24 h urine. Superscript letters represent P 
test). a As compared with group I, b As compared with group 
II.*P<0.05, **P <0.01, ***P<0.001.  
Chart 24:  Effect of Vellai Parpam on ethylene glycol induced urolithiatic activity 
in rats 
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Chart  25:  Effect of Vellai Parpam on ethylene glycol induced urolithiatic 
activity in rats 
 
 
Chart  26:  Effect of Vellai Parpam on ethylene glycol induced urolithiatic 
activity in rats 
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Chart  27:  Effect of Vellai Parpam on ethylene glycol induced urolithiatic 
activity in rats 
 
 
 
Histopathology: 
GroupI- Normal saline 
Group II- Ethylene glycol 
Group III- Vellai Parpam 200 mg/kg 
Group IV- Vellai Parpam 400 mg/kg 
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CONTROL                               ETHYLENE GLYCOL 
 
 
 
 
 
 
 
 
 
 
 
 
                      VELLAI PARPAM 200 mg               VELLAI PARPAM 400 mg                                                  
 
Interpretation: 
The trail drug vellai parpam significantly increased the excretion of calcium, 
oxalate, citrate, uric acid in urinary output of rats compared with the standard drug 
cystone at the dose level of 200 mg and 400 mg/ Kg B.W.  The drug acts more potent 
at the high dose 400mg/Kg than the low dose level of 200 mg/Kg. The 
histopathological results of the trail drug were also confirmed that  there is excretion 
of stone in ethylene glycol induced rats.  Thus the drug vellai parpam exhibits the 
anti-urolithiatic activity. 
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2. Diuretic Activity (Lipschitz Method) 
Table 24: Estimation Of Urinary Electrolytes 
 
Groups Total Urine 
Vol 
(ml/kg/5hrs) 
Na+ mmol/L K+ mmol/L Cl- mmol/L 
Control 
(10ml/kg ) 
13.73± 0.37 102.0± 2.30 45.67± 2.02 72.33± 2.60 
Furosemide  
(10mg/kg) 
23.60± 0.83 
*** 
192.0 ± 2.30 
*** 
78.67± 
1.45*** 
112.7± 5.81 *** 
Vellai Parpam 
(200mg/kg) 
14.23 ± 0.29 
### 
119.3 ± 4.05 
### 
52.00± 
2.30### 
76.67± 2.40 ### 
Vellai Parpam 
(400 mg/kg) 
15.60 ± 0.03 
### 
138.0 ± 2.30 
### 
60.00± 1.15 
### 
86.67± 2.90 ## 
 
Values are Mean ± SEM; n = 6 animals in each group: * P<0.05, ** P< 0.01, *** 
P<0.001 is considered significant when compared with group I; # P<0.05, ## P< 0.01, 
###P<0.001 is considered significant when compared with group II by Tukey multiple 
comparison test.  
Chart 28 : Estimation of Urinary electrolytes 
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Chart 29: Estimation Of Urinary Electrolytes 
 
 
 
 
Chart 30: Estimation Of Urinary Electrolytes 
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Chart 31: Estimation Of Urinary Electrolytes 
 
 
 
Interpretation: 
              At the dose level of 200mg and 400 mg/Kg B.W. the trail drug vellai parpam 
showed the results of there is an increase in the urinary output along with an increase 
in concentration of sodium, potassium and chloride ions in urine. Thus the trail drug 
vellai parpam exhibits the greater diuretic activity when compared with the standard 
drug Furosemide. 
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3. Anti  inflammatory activity 
 
     Table 25 : Carrageenan-induced rat paw edema 
 
Treatment Percentage inflammation after carageenan injection at hr 
1 2 3 4 
Control 30.10± 2.82 74.12± 10.14 131.14± 11.18 138.50± 4.50 
Vellai Parpam 
200mg/kg 
29.00± 3.34 69.28± 1.14 99.34± 1.78  
** 
76.12± 8.08 
** 
Vellai Parpam 
400mg/kg 
20.00± 2.16 69.16± 3.14 77.50± 7.50 
*** 
68.00± 12.18 
*** 
Indomethacin 
10mg/kg 
27.18± 1.28 40.18± 8.98 
** 
48.07± 8.18 
*** 
39.00± 5.26 
*** 
  
Values are Mean ± SEM; n = 6 animals in each group: * P<0.05, ** P< 0.01, *** 
P<0.001 is considered significant when compared with control rats followed by Two 
way ANOVA.  
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Chart 32: Percentage inflammation after carageenan injection at hr,s: 
 
 
 
Interpretation: 
 
            The observed results exhibited the significant inhibition of paw edema in drug 
indomethacin treated group and the drug vellai parpam treated group at the low dose 
level ( 200 mg/Kg BW ) and at the high dose level ( 400 mg/Kg BW). The drug vellai 
parpam treated rats showed the more potent anti-inflammatory activity. 
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DISCUSSION 
 
 
 
 
 
 
92 
 
DISCUSSION 
 
           The drug Vellai Parpam was selected to study the anti urolithiasis, diuretics 
and anti inflammatory activity. The trial drug was selected from Agathiyar Vaithiya 
Kaaviyam 1500 which is indicated for Kalladaippu, Mahodharam, Neerchiruppu, 
Kuttam.   
 The preclinical study substantiated the literary evidence of Vellai Parpam in 
the management of renal calculi. 
 
Chemical analysis: 
           Chemical analysis of the drug Vellai Parpam reveals that the presence of 
Magnesium, Chloride and Calcium. 
  
Magnesium: 
          Magnesium is inhibit the crystals formation. Thus decreasing the risk for 
forming kidney stone. 
 
Chloride:  
             It regulates the water balance by maintaining the osmotic pressure of the body 
fluids and helps maintain proper blood volume, blood pressure and pH of body fluids. 
Calcium : 
            It maintains the water balance in the body and also to maintain the bone 
density.               
               Thus the Chemical constituents of Vellai Parpam help in controlling stone 
formation and maintain the electrolyte balance in the body. 
 
Toxicological studies: 
This study reveals that no significant toxic effect of the  drug Vellai Parpam 
upto the higher dose level 2000mg/kg in acute oral toxicity and also  sub acute 
toxicity and sub chronic toxicity has no toxic effects from the results. Therefore the 
Vellai Parpam can be classified under the category of drug with non-toxic. 
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Pharmacological studies: 
In the Pharmacological study the experimental data showed that the Vellai 
Parpam has anti urolithiatic, diuretic, anti inflammatory activity and the results are as 
follows, 
 
Anti urolithiatic activity: 
 The trail drug vellai parpam significantly increased the excretion of calcium, 
oxalate, citrate, uric acid in urinary output of rats compared with the standard 
drug cystone at the dose level of 200 mg and 400 mg/ Kg B.W.  The drug acts 
more potent at the high dose 400mg/Kg than the low dose level of 200 mg/Kg. 
The histopathological results of the trail drug were also confirmed that there is 
excretion of stone in ethylene glycol induced rats.  Thus the drug vellai 
parpam exhibits the anti-urolithiatic activity. 
 
Diuretic activity: 
 At the dose level of 200mg and 400 mg/Kg B.W. the trail drug vellai parpam 
showed the results of there is an increase in the urinary output along with an 
increase in concentration of sodium, potassium and chloride ions in urine. 
Thus the trail drug vellai parpam exhibits the greater diuretic activity when 
compared with the standard drug Furosemide. 
 
Anti inflammatory activity:   
 The observed results exhibited the significant inhibition of paw edema in drug 
indomethacin treated group and the drug vellai parpam treated group at the 
low dose level ( 200 mg/Kg BW ) and at the high dose level ( 400 mg/Kg 
BW). The drug vellai parpam treated rats showed the more potent anti-
inflammatory activity. 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
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SUMMARY 
 
 The literary evidence of the drug Vellai Parpam strongly support that it 
possesses anti-urolithiatic, diuretic and anti-inflammatory activity for that 
purpose it has been selected for this study.   
 
 The qualitative chemical analysis was done at Biochemistry lab, NIS. 
Chemical analysis of the drug Vellai Parpam reveals that the presence of 
Calcium, Chloride and Magnesium. 
 Preclinical evaluation (acute, sub-acute and sub-chronic toxicity study) of the 
drug was carried out as per OECD guideline. This study reveals no significant 
toxic effect of the Vellai Parpam upto the higher dose level 2000mg/kg used 
in this study. 
 
 Pharmacological study (Anti urolithiatic activity, Diuretic and Anti 
inflammatory activity) of the drug was carried out as per OECD guideline in 
K, K College of Pharmacy, Gerugambakkam, Chennai. In the pharmacological 
studies, the drug Vellai Parpam exhibits significant anti urolithiatic, diuretic 
and anti inflammatory. 
 
 From the results and the statistical analysis it is proved that the drug Vellai 
Parpam is significant of anti urolithiatic, diuretic and anti inflammatory 
activity in the management of renal calculi. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
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CONCLUSION 
 
From the literature evidence, Physico chemical analysis, Chemical analysis, 
Toxicological evaluation and Pharmacological studies, the drug Vellai Parpam has 
anti-urolithiatic, diuretic and anti-inflammatory activity. It is concluded that the drug 
Vellai Parpam can be used in the management of renal calculi and the related urinary 
problems. 
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